The Prevalence of HPV Associated Cervical Intraepithelial Neoplasia in Women under Age 21: Who Will Be Missed under the New Cervical Cancer Screening Guidelines?

Journal of Pediatric and Adolescent Gynecology

Volumn 26, Issue 6, 2013, Pages 346-349

  DeCew, Amanda E ^a   Hadler, James L ^b   Daley, Alison Moriarty ^c   Niccolai, Linda ^b  

^a Community Health Center Inc ^*  (United States)

^b YALE UNIVERSITY   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

Adolescent; Cervical intraepithelial neoplasia; Human papilloma virus; Reproductive health

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER SCREENING; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRECANCER; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; URBAN AREA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADOLESCENT; CERVICAL INTRAEPITHELIAL NEOPLASIA; HUMAN PAPILLOMA VIRUS; REPRODUCTIVE HEALTH;

ADOLESCENT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONNECTICUT; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LOGISTIC MODELS; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PUBLIC HEALTH SURVEILLANCE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84887616766     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2013.06.013     Document Type: Article

References (11)

1. Vesco K.K., Whitlock E.P., Eder M., et al. Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force. Ann Intern Med 2011, 155:698.
2. Plummer M., Schiffman M., Castle P.E., et al. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 2007, 195:1582.
3. Insinga R.P., Dasbach E.J., Elbasha E.H., et al. Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women. Infect Agent Cancer 2007, 2:15.
4. Moscicki A.B. Human papillomavirus disease and vaccines in adolescents. Adolesc Med State Art Rev 2010, 21:347.
5. Moscicki A.B., Ma Y., Wibbelsman C., et al. Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol 2010, 116:1373.
6. Wright T.C., Massad L.S., Dunton C.J., et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007, 197:346.
7. ACOG Practice Bulletin no. 109: Cervical cytology screening. Obstet Gynecol 2009, 114:1409.
8. Saslow D., Solomon D., Lawson H.W., et al. American Cancer Society, American Society for Colposcopy and cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012, 137:516.
9. Kyrgiou M., Koliopoulos G., Martin-Hirsch P., et al. outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006, 367:489.
10. Moore K., Cofer A., Elliot L., et al. Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes. Am J Obstet Gynecol 2007, 197:141.e1.
11. Clements A.E., Raker C.A., Cooper A.S., et al. Prevalence and patient characteristics associated with CIN 3 in adolescents. Am J Obstet Gynecol 2011, 204:128.e1.